Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
Definition: Biological immunotherapy, also known as immunotherapy or immuno-oncology, is a revolutionary approach to cancer treatment that focuses on enhancing the body’s natural immune system to recognize, target, and destroy cancer cells.
Unlike traditional cancer treatments such as chemotherapy or radiation, which directly attack cancer cells (and often harm healthy cells in the process), biological immunotherapy works by empowering the immune system to become more effective at identifying and eliminating cancer cells.
This approach leverages the immune system’s inherent ability to distinguish between normal cells and abnormal or cancerous cells, making it a more targeted and potentially less toxic treatment option.
Dendritic cells are a type of antigen-presenting cell (APC) that play a critical role in the immune system. They act as “messengers” by capturing antigens (foreign substances, such as proteins from cancer cells) and presenting them to other immune cells, such as T-cells, to initiate an immune response.
How It Works:
In dendritic cell therapy, dendritic cells are harvested from the patient’s blood or tumor tissue. These cells are then exposed to cancer-specific antigens in the laboratory, effectively “reprogramming” them to recognize the patient’s cancer. Once reintroduced into the patient’s body, these activated dendritic cells “teach” the immune system to identify and attack cancer cells.
Applications:
This therapy is particularly promising in cancers like melanoma, prostate cancer, and glioblastoma, where specific tumor antigens can be targeted.
What are Cytokines?
Cytokines are small proteins that act as signaling molecules in the immune system. They regulate immune responses by stimulating or inhibiting the activity of immune cells. Examples include interleukins (e.g., IL-2) and interferons (e.g., IFN-alpha).
How It Works:
Cytokine therapy involves administering synthetic or naturally occurring cytokines to boost the immune system’s ability to fight cancer. For example:
Applications:
Cytokine therapy is commonly used in renal cell carcinoma, melanoma, and certain blood cancers.
What are NK Cells?
Natural Killer (NK) cells are a type of lymphocyte that can recognize and kill abnormal cells, including cancer cells, without prior exposure. They are part of the body’s innate immune system and play a key role in immune surveillance.
How It Works:
In NK cell therapy, NK cells are extracted from the patient’s blood or a donor’s blood. These cells are then activated and expanded in the laboratory to increase their numbers and killing potential. The activated NK cells are then infused back into the patient, where they seek out and destroy cancerous tissues.
Applications:
NK cell therapy shows promise in treating hematologic malignancies (e.g., leukemia, lymphoma) and certain solid tumors.
Biological immunotherapy can slow or even halt cancer progression by enhancing the immune system’s ability to detect and eliminate cancer cells.
Most effective in early-stage cancers or slow-growing tumors, where the immune system is more likely to mount a robust response.
Some late-stage cancer patients experience benefits such as improved quality of life, reduced tumor burden, and prolonged survival.
Immunotherapy can be combined with traditional treatments like chemotherapy, radiation, or surgery to enhance overall efficacy:
Chemotherapy: May weaken cancer cells, making them more susceptible to immune attack.
Radiation: Can release tumor antigens, making it easier for the immune system to recognize cancer cells.
This combination approach, known as combination therapy, is increasingly used in clinical practice.
One of the most significant advantages of immunotherapy is its potential to provide long-lasting immune memory. This means that the immune system may continue to recognize and attack cancer cells even after treatment has ended, reducing the risk of recurrence.
A typical treatment cycle lasts several weeks, with multiple sessions of infusions or injections.
The exact duration depends on the type of immunotherapy, the stage of cancer, and the patient’s response to treatment. For example:
Treatments are often administered in cycles, with rest periods in between to allow the immune system to recover and respond.
Maintenance therapy may be recommended to sustain immune activity over time.
Patients undergo regular monitoring through blood tests, imaging scans, and biomarker analysis to assess treatment efficacy and adjust the plan as needed.
The cost of biological immunotherapy varies widely depending on the type of treatment, the complexity of preparation, and the country or facility providing the therapy.
On average, costs range from €14,600 to €46,000 per treatment cycle.
Dendritic cell vaccines: Typically on the higher end due to the labor-intensive process of cell extraction, reprogramming, and reinfusion.
Cytokine therapy: Generally less expensive but may require frequent administration.
NK cell therapy: Costs depend on whether cells are sourced from the patient or a donor, and the extent of lab processing required.
Biological immunotherapy represents a transformative approach in cancer treatment, offering hope for patients with various types and stages of cancer. By harnessing the power of the immune system, this therapy not only targets cancer cells but also provides the potential for long-term protection against recurrence. While costs and accessibility remain challenges, ongoing research and advancements are expected to improve efficacy, reduce side effects, and make these treatments more widely available.
WEGOVITA offers medical coordination services by connecting international patients with top hospitals and specialists across Germany. We support access to expert evaluations, facilitate treatment logistics, and present a range of available medical options.
However, WEGOVITA does not provide direct medical treatment, make medical diagnoses, or recommend specific therapies. All final medical decisions—including diagnosis, treatment planning, and cost—are made solely by licensed medical professionals after a full clinical assessment of the individual patient.
This information is provided for informational purposes, based on internationally recognized guidelines and practices used in Germany’s leading medical institutions. It is not a substitute for professional medical advice.
💡 Interested in clinical trial references, treatment innovations, or cost comparisons? Contact our medical coordination team at info@wegovita.com for personalized assistance.
Your Health. Your Journey. With WEGOVITA.